Identification of 4 immune cells and a 5-lncRNA risk signature with prognosis for early-stage lung adenocarcinoma

被引：0
|
作者：
Lan Mu
Ke Ding
Ranran Tu
Wei Yang
机构：
[1] Central South University,Department of Thyroid Surgery, The Second Xiangya Hospital
[2] Central South University,Department of Urology, Xiangya Hospital
[3] Central South University,Department of Neurology, The Second Xiangya Hospital
[4] Central South University,Department of Respiratory Medicine, National Key Clinical Specialty, Xiangya Hospital
来源：
Journal of Translational Medicine | / 19卷
关键词：
Lung adenocarcinoma; Immune infiltration; LncRNA; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution
    Liu, Jun
    Ji, Yaxin
    Weng, Xiaodan
    Shao, Wei
    Zhao, Jiaping
    Chen, Hanlin
    Shen, Lu
    Wang, Fufeng
    Meng, Qi
    Wu, Xue
    Wang, Xiaonan
    Ou, Qiuxiang
    Ke, Honggang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma
    Kadara, Humam
    Choi, Murim
    Zhang, Jiexin
    Cuentas, Edwin Parra
    Canales, Jaime Rodriguez
    Gaffney, Stephen
    Zhao, Zi-Ming
    Behrens, Carmen
    Fujimoto, Junya
    Chow, Chi-Wan
    Kalhor, Neda
    Moran, Cesar
    Rimm, David
    Swisher, Stephen G.
    Gibbons, Don L.
    Heynnach, John V.
    Kaftan, Edward
    Townsend, Jeffrey
    Lynch, Thomas J.
    Schlessinger, Joseph
    Lee, J. Jack
    Lifton, Richard
    Wistuba, Ignacio I.
    Herbst, Roy S.
    CANCER RESEARCH, 2016, 76
  • [43] STAINING PATTERN OF TYPE-IV COLLAGEN AND PROGNOSIS IN EARLY-STAGE ADENOCARCINOMA OF THE LUNG
    WATANABE, N
    NAKAJIMA, I
    ABE, S
    OGURA, S
    ISOBE, H
    KAWAKAMI, Y
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (07) : 613 - 615
  • [44] Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma
    Izaki, Yu
    Mimae, Takahiro
    Kagimoto, Atsushi
    Handa, Yoshinori
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Okada, Morihito
    Takeshima, Yukio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (07) : 813 - 821
  • [45] Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma
    Cai, Qidong
    Zhang, Pengfei
    He, Boxue
    Zhao, Zhenyu
    Zhang, Yuqian
    Peng, Xiong
    Xie, Hui
    Wang, Xiang
    CANCER GENETICS, 2020, 246 : 1 - 11
  • [46] Gene expression profiling and molecular pathway analysis for the identification of early-stage lung adenocarcinoma patients at risk for early recurrence
    Saji, Hisashi
    Tsuboi, Masahiro
    Shimada, Yoshihisa
    Kato, Yasufumi
    Hamanaka, Wakako
    Kudo, Yujin
    Yoshida, Koichi
    Matsubayashi, Jun
    Usuda, Jitsuo
    Ohira, Tatsuo
    Ikeda, Norihiko
    ONCOLOGY REPORTS, 2013, 29 (05) : 1902 - 1906
  • [47] Identification of early-stage lung adenocarcinoma prognostic signatures based on statistical modeling
    Wu, Chunxiao
    Zhang, Donglei
    CANCER BIOMARKERS, 2017, 18 (02) : 117 - 123
  • [48] Response to comment on 'Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma'
    Sun, Nan
    Zhang, Chaoqi
    He, Jie
    CANCER LETTERS, 2020, 494 : 5 - 6
  • [49] Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients
    Ke, Jia
    Liu, Xuan-hui
    Jiang, Xiao-feng
    He, Zhen
    Xiao, Jian
    Zheng, Bin
    Chen, Yu-feng
    Cai, Ze-rong
    Zheng, Xiao-bin
    Zou, Yi-feng
    Lan, Ping
    Wu, Xiao-jian
    Gao, Feng
    EJSO, 2020, 46 (10): : E62 - E70
  • [50] Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
    Zhang, Hongpan
    Liu, Meihan
    Yang, Zhihao
    Du, Guobo
    Yu, Bin
    Gui, Yan
    Cao, Lu
    Li, Xianfu
    Tan, Bangxian
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345